Company Profile

Company Description

Aadi Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing precision therapies for genetically defined cancers. Specializing in rare and aggressive tumors, it leverages advanced research to target mTOR pathway dysregulation. The company aims to address unmet medical needs by developing innovative treatments that improve patient outcomes, particularly in oncology. Its pipeline includes therapies designed for specific genetic mutations, offering personalized solutions for challenging cancers. With a commitment to scientific excellence, it collaborates with researchers and clinicians to advance novel therapeutic approaches. The company's mission centers on transforming cancer care through precision medicine and targeted drug development.